Sanofi Stock Price Today
Sanofi stock price today. Sanofi (MX:SNYN) is currently trading at MX$855.00 MXN, up 0.88% today. Over the past 52 weeks, shares have ranged between MX$724.00 and MX$955.00. This page tracks Sanofi's live share price on the MX exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Sanofi (SNYN) market capitalisation.
Share Price of Sanofi — Daily History & Trading Volume
Share price of Sanofi over the past year. The chart below tracks Sanofi's daily closing share price and trading volume on the MX exchange over the past year, giving a clear view of recent price momentum and liquidity.
Sanofi Stock Trading Volume
Sanofi stock trading volume shows how many shares changed hands each day on the MX exchange.
Sanofi Income Statement — Revenue, Profit & Earnings by Year
Sanofi's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | MX$46.72 Billion | MX$44.29 Billion | MX$41.62 Billion | MX$45.39 Billion | MX$39.17 Billion |
| Cost of Revenue | MX$13.05 Billion | MX$13.21 Billion | MX$12.63 Billion | MX$13.70 Billion | MX$12.26 Billion |
| Gross Profit | MX$33.67 Billion | MX$31.08 Billion | MX$28.99 Billion | MX$31.69 Billion | MX$26.92 Billion |
| Research & Development | MX$7.84 Billion | MX$7.39 Billion | MX$6.51 Billion | MX$6.71 Billion | MX$5.69 Billion |
| SG&A | MX$10.24 Billion | MX$9.82 Billion | MX$9.48 Billion | MX$10.49 Billion | MX$9.55 Billion |
| Total Operating Expenses | MX$37.12 Billion | MX$35.36 Billion | MX$32.93 Billion | MX$33.51 Billion | MX$30.03 Billion |
| Operating Income | MX$9.60 Billion | MX$8.92 Billion | MX$8.69 Billion | MX$11.88 Billion | MX$9.15 Billion |
| EBITDA | — | — | — | MX$10.76 Billion | MX$9.75 Billion |
| EBIT | — | — | — | MX$11.04 Billion | MX$8.56 Billion |
| Interest Expense | MX$626.00 Million | MX$704.00 Million | MX$643.00 Million | MX$440.00 Million | MX$403.00 Million |
| Income Before Tax | MX$6.17 Billion | MX$6.70 Billion | MX$6.25 Billion | MX$8.27 Billion | MX$7.80 Billion |
| Income Tax Expense | — | — | — | MX$2.01 Billion | MX$1.56 Billion |
| Net Income | MX$7.81 Billion | MX$5.56 Billion | MX$5.40 Billion | MX$6.72 Billion | MX$6.22 Billion |
Sanofi Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Sanofi's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | MX$126.81 Billion | MX$132.80 Billion | MX$126.46 Billion | MX$124.58 Billion | MX$120.24 Billion |
| Total Current Assets | MX$30.95 Billion | MX$42.59 Billion | MX$30.67 Billion | MX$34.11 Billion | MX$30.65 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | MX$810.00 Million | MX$486.00 Million | MX$270.00 Million | MX$664.00 Million | MX$1.05 Billion |
| Net Receivables | MX$8.41 Billion | MX$7.68 Billion | MX$8.43 Billion | MX$8.42 Billion | MX$7.57 Billion |
| Inventory | MX$10.21 Billion | MX$9.43 Billion | MX$9.67 Billion | MX$8.96 Billion | MX$8.71 Billion |
| Property, Plant & Equipment | — | — | — | MX$11.68 Billion | MX$11.98 Billion |
| Goodwill | MX$41.30 Billion | MX$43.38 Billion | MX$49.40 Billion | MX$49.89 Billion | MX$48.06 Billion |
| Total Liabilities | MX$55.09 Billion | MX$54.94 Billion | MX$52.11 Billion | MX$51.07 Billion | MX$51.21 Billion |
| Total Current Liabilities | MX$28.34 Billion | MX$29.16 Billion | MX$24.21 Billion | MX$23.97 Billion | MX$21.30 Billion |
| Long-term Debt | MX$14.25 Billion | MX$11.79 Billion | MX$14.35 Billion | MX$14.86 Billion | MX$17.12 Billion |
| Net Debt | MX$10.93 Billion | MX$8.56 Billion | MX$7.68 Billion | MX$6.29 Billion | MX$10.21 Billion |
| Total Stockholder Equity | MX$71.38 Billion | MX$77.51 Billion | MX$74.04 Billion | MX$73.14 Billion | MX$68.68 Billion |
| Retained Earnings | — | — | — | — | — |
Sanofi Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Sanofi generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | MX$10.75 Billion | MX$9.08 Billion | MX$10.26 Billion | MX$10.53 Billion | MX$10.52 Billion |
| Capital Expenditures | MX$3.54 Billion | MX$3.19 Billion | MX$3.02 Billion | MX$1.61 Billion | MX$1.48 Billion |
| Free Cash Flow | MX$7.21 Billion | MX$5.89 Billion | MX$7.23 Billion | MX$8.32 Billion | MX$8.48 Billion |
| Investing Cash Flow | — | — | — | MX$-2.08 Billion | MX$-7.30 Billion |
| Financing Cash Flow | MX$-8.16 Billion | MX$-5.75 Billion | MX$-8.05 Billion | MX$-5.82 Billion | MX$-7.06 Billion |
| Dividends Paid | MX$4.77 Billion | MX$4.70 Billion | MX$4.45 Billion | MX$4.17 Billion | MX$4.01 Billion |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | MX$5.68 Billion | MX$3.59 Billion | MX$4.79 Billion | MX$3.37 Billion | MX$3.00 Billion |
| Change in Cash | MX$216.00 Million | MX$-1.27 Billion | MX$-4.03 Billion | MX$2.64 Billion | MX$-3.82 Billion |
Sanofi Earnings History — EPS Actual vs. Analyst Estimates
Track Sanofi's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Oct 30, 2026 | — | 1.56 | — |
| Jul 30, 2026 | — | 1.14 | — |
| Apr 23, 2026 | — | 1.03 | — |
| Jan 29, 2026 | — | 0.81 | — |
| Oct 24, 2025 | — | 1.58 | — |
| Jul 31, 2025 | — | 1.00 | — |
| Apr 24, 2025 | — | — | — |